All the latest UK technology news, reviews and analysis
|
|
|
28 Oct 2010
Russian police are reported to have filed a criminal case against a man accused of being one of the world's most prolific spammers.
Igor Gusev and his company Despmedia are accused of running a huge pharmaceutical spam operation that police estimate generated $120m (£75m) in three and a half years, primarily by selling counterfeit pharmaceuticals such as Viagra.
Russia's Federal Security Service closed down the spamdot.biz web site last year, which was reportedly run by Glavmed.com, which was controlled by Despmedia.
Police raided Gusev's home on 26 October, and said that, as far as they are aware, he is not in Russia at the moment, but that they are actively looking for him. Gusev is thought to have made $2m (£1.25m) personally from his businesses.
Gusev's lawyer, Vadim Kolosov, confirmed to Reuters that a criminal case had been opened against his client, but maintained that he "has no relation to these activities".
Russia has become an increasingly popular location for online criminals, particularly since the Chinese government took steps to crack down on abuse within its borders.
Latest stories from Security
Related videos
Related articles
Related jobs
Poll
Are you confident that the UK's IT infrastructure is secure from attack in the wake of the Flame malware revelations?
V3 examines the key strengths and weaknesses of Samsung's latest iPhone killer
Connect with V3.co.uk
Social networking is almost ubiquitous. This white paper examines the benefits and risks and it looks at the different ways companies can reconcile them
The importance of understanding your infrastructure
As part of a major implementation of a new inventory...
Information/Data Architect - MDM - Master Data Management...
Code Red Associates (CRA) is a leading supplier of Permanent...
A fantastic opportunity has arisen for an experienced...
Keep up to date with the latest products, services and technologies from the world's leading IT companies. IThound.com brings you over 2,000 white papers, case studies and analyst reports.
Do you agree?